|
gptkbp:instanceOf
|
gptkb:drug
antihistamine
|
|
gptkbp:approvalYear
|
1996
|
|
gptkbp:approvedBy
|
gptkb:United_States
|
|
gptkbp:ATCCode
|
S01GX09
R01AC09
|
|
gptkbp:brand
|
gptkb:Pataday
gptkb:Patanol
gptkb:Pazeo
|
|
gptkbp:CASNumber
|
140462-76-6
|
|
gptkbp:chemicalClass
|
diarylethylamine
|
|
gptkbp:contraindication
|
hypersensitivity to olopatadine
|
|
gptkbp:developedBy
|
gptkb:Kyowa_Hakko_Kirin
|
|
gptkbp:eliminationHalfLife
|
8-12 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
oral tablet
eye drops
|
|
gptkbp:hasMolecularFormula
|
C21H23NO3
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
olopatadine
|
|
gptkbp:KEGGID
|
D08248
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
histamine H1 receptor antagonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:PubChem_CID
|
4583
CHEMBL1201312
DB00768
|
|
gptkbp:routeOfAdministration
|
oral
ophthalmic
|
|
gptkbp:sideEffect
|
headache
dry mouth
eye irritation
|
|
gptkbp:synonym
|
olopatadine hydrochloride
olopatadinum
|
|
gptkbp:UNII
|
A4M8Z416LX
|
|
gptkbp:usedFor
|
allergic rhinitis
allergic conjunctivitis
|
|
gptkbp:bfsParent
|
gptkb:Pataday
|
|
gptkbp:bfsLayer
|
5
|